| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 3004 |
| 1 | DUPILUMAB | 1021 |
| 2 | ADALIMUMAB | 924 |
| 3 | CERTOLIZUMAB PEGOL | 677 |
| 4 | EVOLOCUMAB | 553 |
| 5 | METHOTREXATE | 525 |
| 6 | METHOTREXATE SODIUM | 523 |
| 7 | TERIPARATIDE | 402 |
| 8 | PREDNISONE | 400 |
| 9 | INTERFERON BETA-1A | 391 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRADECYL HYDROGEN SULFATE (ESTER) | 9 | 0.1059 |
| 1 | ASFOTASE ALFA | 267 | 0.0259 |
| 2 | OLEZARSEN SODIUM | 20 | 0.0211 |
| 3 | REPOSITORY CORTICOTROPIN | 88 | 0.0197 |
| 4 | FLORBETAPIR F 18 | 2 | 0.0174 |
| 5 | DONIDALORSEN | 8 | 0.0158 |
| 6 | DEOXYCHOLIC ACID | 31 | 0.0133 |
| 7 | ERGOCALCIFEROL | 341 | 0.0115 |
| 8 | GLATIRAMER ACETATE INJECTION | 42 | 0.0089 |
| 9 | RITUXIMAB AND HYALURONIDASE | 4 | 0.0088 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 3736 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1021 |
| 2 | Corticosteroid [EPC] | 683 |
| 3 | PCSK9 Inhibitor [EPC] | 674 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 604 |
| 5 | GLP-1 Receptor Agonist [EPC] | 548 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 507 |
| 7 | Interferon beta [EPC] | 464 |
| 8 | Vitamin C [EPC] | 424 |
| 9 | Insulin Analog [EPC] | 409 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 88 | 0.0983 |
| 1 | Disclosing Agent [EPC] | 1 | 0.0476 |
| 2 | Interleukin-5 Antagonist [EPC] | 21 | 0.0305 |
| 3 | PCSK9 Inhibitor [EPC] | 674 | 0.0262 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 267 | 0.0259 |
| 5 | Sclerosing Agent [EPC] | 8 | 0.0178 |
| 6 | Cytolytic Agent [EPC] | 31 | 0.0133 |
| 7 | Provitamin D2 Compound [EPC] | 341 | 0.0115 |
| 8 | Endoglycosidase [EPC] | 19 | 0.0103 |
| 9 | Skin Test Antigen [EPC] | 14 | 0.0074 |